Fenebrutinib Maintains Low Levels of Multiple Sclerosis Activity for 96 Weeks
Although there is no cure for MS, treatment focuses on recovery from attacks, reducing relapse, slowing disease progression, and managing multiple sclerosis symptoms.
The Pharmacist-Developed Tool Helping Mitigate Drug Shortages
In a world where drug shortages are one of the most pressing issues for pharmacy businesses, there are certain tools making a significant difference in helping patients access their drugs at the pharmacy.
CVS, Express Scripts Sue to Overturn Arkansas Law Banning PBMs From Owning Pharmacies
In the suit, the companies claim the law puts an unconstitutional restriction on interstate commerce.
The Common Trends in Hepatitis Vaccine Uptake, Hesitancy
During Viral Hepatitis Awareness Month, Jeff Goad, PharmD, MPH, joined Over the Counter to discuss hepatitis vaccines and the common trends pharmacists in this space should keep in mind.
Q&A: Pharmaceutical Tariffs Could Result in Generic Drug Shortages
Health care economist Marta Wosinska, PhD, senior fellow with The Brookings Institution, discussed the potential impact pharmaceutical tariffs may have on access to generic and brand-name drugs.
HIV Drug Shows Potential as Oral Treatment for Diabetic Macular Edema
The results show promise, as vision typically improves the most during the first 4 weeks, but with lamivudine, vision continued to improve in the following 4 weeks.
